Global Metabolomics Biomarker Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 325046
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Metabolomics Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Metabolomics Biomarker market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Toxicological studies accounting for % of the Metabolomics Biomarker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Protein Marker segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Metabolomics Biomarker include Biocrates Life Sciences, Biomark Diagnostics, Chenomx, Creative Proteomics, and Evotec, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Metabolomics Biomarker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Protein Marker

Nucleic Acid Marker

Market segment by Application, can be divided into

Toxicological studies

Drug testing

Cancer

Cardiovascular disorders

Neurological disorders

Inborn errors of metabolism

Market segment by players, this report covers

Biocrates Life Sciences

Biomark Diagnostics

Chenomx

Creative Proteomics

Evotec

Human Metabolome Technologies

Merck

Metabolomic Diagnostics

Metabolon

Ovid Therapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Metabolomics Biomarker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Metabolomics Biomarker, with revenue, gross margin and global market share of Metabolomics Biomarker from 2019 to 2022.

Chapter 3, the Metabolomics Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Metabolomics Biomarker market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Metabolomics Biomarker research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Metabolomics Biomarker

1.2 Classification of Metabolomics Biomarker by Type

1.2.1 Overview: Global Metabolomics Biomarker Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Metabolomics Biomarker Revenue Market Share by Type in 2021

1.2.3 Protein Marker

1.2.4 Nucleic Acid Marker

1.3 Global Metabolomics Biomarker Market by Application

1.3.1 Overview: Global Metabolomics Biomarker Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Toxicological studies

1.3.3 Drug testing

1.3.4 Cancer

1.3.5 Cardiovascular disorders

1.3.6 Neurological disorders

1.3.7 Inborn errors of metabolism

1.4 Global Metabolomics Biomarker Market Size & Forecast

1.5 Global Metabolomics Biomarker Market Size and Forecast by Region

1.5.1 Global Metabolomics Biomarker Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Metabolomics Biomarker Market Size by Region, (2017-2022)

1.5.3 North America Metabolomics Biomarker Market Size and Prospect (2017-2028)

1.5.4 Europe Metabolomics Biomarker Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Metabolomics Biomarker Market Size and Prospect (2017-2028)

1.5.6 South America Metabolomics Biomarker Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Metabolomics Biomarker Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Metabolomics Biomarker Market Drivers

1.6.2 Metabolomics Biomarker Market Restraints

1.6.3 Metabolomics Biomarker Trends Analysis

2 Company Profiles

2.1 Biocrates Life Sciences

2.1.1 Biocrates Life Sciences Details

2.1.2 Biocrates Life Sciences Major Business

2.1.3 Biocrates Life Sciences Metabolomics Biomarker Product and Solutions

2.1.4 Biocrates Life Sciences Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Biocrates Life Sciences Recent Developments and Future Plans

2.2 Biomark Diagnostics

2.2.1 Biomark Diagnostics Details

2.2.2 Biomark Diagnostics Major Business

2.2.3 Biomark Diagnostics Metabolomics Biomarker Product and Solutions

2.2.4 Biomark Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Biomark Diagnostics Recent Developments and Future Plans

2.3 Chenomx

2.3.1 Chenomx Details

2.3.2 Chenomx Major Business

2.3.3 Chenomx Metabolomics Biomarker Product and Solutions

2.3.4 Chenomx Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Chenomx Recent Developments and Future Plans

2.4 Creative Proteomics

2.4.1 Creative Proteomics Details

2.4.2 Creative Proteomics Major Business

2.4.3 Creative Proteomics Metabolomics Biomarker Product and Solutions

2.4.4 Creative Proteomics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Creative Proteomics Recent Developments and Future Plans

2.5 Evotec

2.5.1 Evotec Details

2.5.2 Evotec Major Business

2.5.3 Evotec Metabolomics Biomarker Product and Solutions

2.5.4 Evotec Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Evotec Recent Developments and Future Plans

2.6 Human Metabolome Technologies

2.6.1 Human Metabolome Technologies Details

2.6.2 Human Metabolome Technologies Major Business

2.6.3 Human Metabolome Technologies Metabolomics Biomarker Product and Solutions

2.6.4 Human Metabolome Technologies Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Human Metabolome Technologies Recent Developments and Future Plans

2.7 Merck

2.7.1 Merck Details

2.7.2 Merck Major Business

2.7.3 Merck Metabolomics Biomarker Product and Solutions

2.7.4 Merck Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Merck Recent Developments and Future Plans

2.8 Metabolomic Diagnostics

2.8.1 Metabolomic Diagnostics Details

2.8.2 Metabolomic Diagnostics Major Business

2.8.3 Metabolomic Diagnostics Metabolomics Biomarker Product and Solutions

2.8.4 Metabolomic Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Metabolomic Diagnostics Recent Developments and Future Plans

2.9 Metabolon

2.9.1 Metabolon Details

2.9.2 Metabolon Major Business

2.9.3 Metabolon Metabolomics Biomarker Product and Solutions

2.9.4 Metabolon Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Metabolon Recent Developments and Future Plans

2.10 Ovid Therapeutics

2.10.1 Ovid Therapeutics Details

2.10.2 Ovid Therapeutics Major Business

2.10.3 Ovid Therapeutics Metabolomics Biomarker Product and Solutions

2.10.4 Ovid Therapeutics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Ovid Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Metabolomics Biomarker Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Metabolomics Biomarker Players Market Share in 2021

3.2.2 Top 10 Metabolomics Biomarker Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Metabolomics Biomarker Players Head Office, Products and Services Provided

3.4 Metabolomics Biomarker Mergers & Acquisitions

3.5 Metabolomics Biomarker New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Metabolomics Biomarker Revenue and Market Share by Type (2017-2022)

4.2 Global Metabolomics Biomarker Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Metabolomics Biomarker Revenue Market Share by Application (2017-2022)

5.2 Global Metabolomics Biomarker Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Metabolomics Biomarker Revenue by Type (2017-2028)

6.2 North America Metabolomics Biomarker Revenue by Application (2017-2028)

6.3 North America Metabolomics Biomarker Market Size by Country

6.3.1 North America Metabolomics Biomarker Revenue by Country (2017-2028)

6.3.2 United States Metabolomics Biomarker Market Size and Forecast (2017-2028)

6.3.3 Canada Metabolomics Biomarker Market Size and Forecast (2017-2028)

6.3.4 Mexico Metabolomics Biomarker Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Metabolomics Biomarker Revenue by Type (2017-2028)

7.2 Europe Metabolomics Biomarker Revenue by Application (2017-2028)

7.3 Europe Metabolomics Biomarker Market Size by Country

7.3.1 Europe Metabolomics Biomarker Revenue by Country (2017-2028)

7.3.2 Germany Metabolomics Biomarker Market Size and Forecast (2017-2028)

7.3.3 France Metabolomics Biomarker Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Metabolomics Biomarker Market Size and Forecast (2017-2028)

7.3.5 Russia Metabolomics Biomarker Market Size and Forecast (2017-2028)

7.3.6 Italy Metabolomics Biomarker Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Metabolomics Biomarker Revenue by Type (2017-2028)

8.2 Asia-Pacific Metabolomics Biomarker Revenue by Application (2017-2028)

8.3 Asia-Pacific Metabolomics Biomarker Market Size by Region

8.3.1 Asia-Pacific Metabolomics Biomarker Revenue by Region (2017-2028)

8.3.2 China Metabolomics Biomarker Market Size and Forecast (2017-2028)

8.3.3 Japan Metabolomics Biomarker Market Size and Forecast (2017-2028)

8.3.4 South Korea Metabolomics Biomarker Market Size and Forecast (2017-2028)

8.3.5 India Metabolomics Biomarker Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Metabolomics Biomarker Market Size and Forecast (2017-2028)

8.3.7 Australia Metabolomics Biomarker Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Metabolomics Biomarker Revenue by Type (2017-2028)

9.2 South America Metabolomics Biomarker Revenue by Application (2017-2028)

9.3 South America Metabolomics Biomarker Market Size by Country

9.3.1 South America Metabolomics Biomarker Revenue by Country (2017-2028)

9.3.2 Brazil Metabolomics Biomarker Market Size and Forecast (2017-2028)

9.3.3 Argentina Metabolomics Biomarker Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Metabolomics Biomarker Revenue by Type (2017-2028)

10.2 Middle East & Africa Metabolomics Biomarker Revenue by Application (2017-2028)

10.3 Middle East & Africa Metabolomics Biomarker Market Size by Country

10.3.1 Middle East & Africa Metabolomics Biomarker Revenue by Country (2017-2028)

10.3.2 Turkey Metabolomics Biomarker Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Metabolomics Biomarker Market Size and Forecast (2017-2028)

10.3.4 UAE Metabolomics Biomarker Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Metabolomics Biomarker Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Metabolomics Biomarker Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Metabolomics Biomarker Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Metabolomics Biomarker Revenue (USD Million) by Region (2017-2022)

Table 5. Global Metabolomics Biomarker Revenue Market Share by Region (2023-2028)

Table 6. Biocrates Life Sciences Corporate Information, Head Office, and Major Competitors

Table 7. Biocrates Life Sciences Major Business

Table 8. Biocrates Life Sciences Metabolomics Biomarker Product and Solutions

Table 9. Biocrates Life Sciences Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Biomark Diagnostics Corporate Information, Head Office, and Major Competitors

Table 11. Biomark Diagnostics Major Business

Table 12. Biomark Diagnostics Metabolomics Biomarker Product and Solutions

Table 13. Biomark Diagnostics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Chenomx Corporate Information, Head Office, and Major Competitors

Table 15. Chenomx Major Business

Table 16. Chenomx Metabolomics Biomarker Product and Solutions

Table 17. Chenomx Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Creative Proteomics Corporate Information, Head Office, and Major Competitors

Table 19. Creative Proteomics Major Business

Table 20. Creative Proteomics Metabolomics Biomarker Product and Solutions

Table 21. Creative Proteomics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Evotec Corporate Information, Head Office, and Major Competitors

Table 23. Evotec Major Business

Table 24. Evotec Metabolomics Biomarker Product and Solutions

Table 25. Evotec Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Human Metabolome Technologies Corporate Information, Head Office, and Major Competitors

Table 27. Human Metabolome Technologies Major Business

Table 28. Human Metabolome Technologies Metabolomics Biomarker Product and Solutions

Table 29. Human Metabolome Technologies Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Merck Corporate Information, Head Office, and Major Competitors

Table 31. Merck Major Business

Table 32. Merck Metabolomics Biomarker Product and Solutions

Table 33. Merck Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Metabolomic Diagnostics Corporate Information, Head Office, and Major Competitors

Table 35. Metabolomic Diagnostics Major Business

Table 36. Metabolomic Diagnostics Metabolomics Biomarker Product and Solutions

Table 37. Metabolomic Diagnostics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Metabolon Corporate Information, Head Office, and Major Competitors

Table 39. Metabolon Major Business

Table 40. Metabolon Metabolomics Biomarker Product and Solutions

Table 41. Metabolon Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Ovid Therapeutics Corporate Information, Head Office, and Major Competitors

Table 43. Ovid Therapeutics Major Business

Table 44. Ovid Therapeutics Metabolomics Biomarker Product and Solutions

Table 45. Ovid Therapeutics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Metabolomics Biomarker Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Metabolomics Biomarker Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Metabolomics Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Metabolomics Biomarker Players Head Office, Products and Services Provided

Table 50. Metabolomics Biomarker Mergers & Acquisitions in the Past Five Years

Table 51. Metabolomics Biomarker New Entrants and Expansion Plans

Table 52. Global Metabolomics Biomarker Revenue (USD Million) by Type (2017-2022)

Table 53. Global Metabolomics Biomarker Revenue Share by Type (2017-2022)

Table 54. Global Metabolomics Biomarker Revenue Forecast by Type (2023-2028)

Table 55. Global Metabolomics Biomarker Revenue by Application (2017-2022)

Table 56. Global Metabolomics Biomarker Revenue Forecast by Application (2023-2028)

Table 57. North America Metabolomics Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Metabolomics Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Metabolomics Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Metabolomics Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Metabolomics Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Metabolomics Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Metabolomics Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Metabolomics Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Metabolomics Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Metabolomics Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Metabolomics Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Metabolomics Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Metabolomics Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Metabolomics Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Metabolomics Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Metabolomics Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Metabolomics Biomarker Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Metabolomics Biomarker Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Metabolomics Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Metabolomics Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Metabolomics Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Metabolomics Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Metabolomics Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Metabolomics Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Metabolomics Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Metabolomics Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Metabolomics Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Metabolomics Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Metabolomics Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Metabolomics Biomarker Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Metabolomics Biomarker Picture

Figure 2. Global Metabolomics Biomarker Revenue Market Share by Type in 2021

Figure 3. Protein Marker

Figure 4. Nucleic Acid Marker

Figure 5. Metabolomics Biomarker Revenue Market Share by Application in 2021

Figure 6. Toxicological studies Picture

Figure 7. Drug testing Picture

Figure 8. Cancer Picture

Figure 9. Cardiovascular disorders Picture

Figure 10. Neurological disorders Picture

Figure 11. Inborn errors of metabolism Picture

Figure 12. Global Metabolomics Biomarker Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Metabolomics Biomarker Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Metabolomics Biomarker Revenue Market Share by Region (2017-2028)

Figure 15. Global Metabolomics Biomarker Revenue Market Share by Region in 2021

Figure 16. North America Metabolomics Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Metabolomics Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Metabolomics Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Metabolomics Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Metabolomics Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Metabolomics Biomarker Market Drivers

Figure 22. Metabolomics Biomarker Market Restraints

Figure 23. Metabolomics Biomarker Market Trends

Figure 24. Biocrates Life Sciences Recent Developments and Future Plans

Figure 25. Biomark Diagnostics Recent Developments and Future Plans

Figure 26. Chenomx Recent Developments and Future Plans

Figure 27. Creative Proteomics Recent Developments and Future Plans

Figure 28. Evotec Recent Developments and Future Plans

Figure 29. Human Metabolome Technologies Recent Developments and Future Plans

Figure 30. Merck Recent Developments and Future Plans

Figure 31. Metabolomic Diagnostics Recent Developments and Future Plans

Figure 32. Metabolon Recent Developments and Future Plans

Figure 33. Ovid Therapeutics Recent Developments and Future Plans

Figure 34. Global Metabolomics Biomarker Revenue Share by Players in 2021

Figure 35. Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Metabolomics Biomarker Revenue Market Share in 2021

Figure 37. Global Top 10 Players Metabolomics Biomarker Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Metabolomics Biomarker Revenue Share by Type in 2021

Figure 40. Global Metabolomics Biomarker Market Share Forecast by Type (2023-2028)

Figure 41. Global Metabolomics Biomarker Revenue Share by Application in 2021

Figure 42. Global Metabolomics Biomarker Market Share Forecast by Application (2023-2028)

Figure 43. North America Metabolomics Biomarker Sales Market Share by Type (2017-2028)

Figure 44. North America Metabolomics Biomarker Sales Market Share by Application (2017-2028)

Figure 45. North America Metabolomics Biomarker Revenue Market Share by Country (2017-2028)

Figure 46. United States Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Metabolomics Biomarker Sales Market Share by Type (2017-2028)

Figure 50. Europe Metabolomics Biomarker Sales Market Share by Application (2017-2028)

Figure 51. Europe Metabolomics Biomarker Revenue Market Share by Country (2017-2028)

Figure 52. Germany Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Metabolomics Biomarker Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Metabolomics Biomarker Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Metabolomics Biomarker Revenue Market Share by Region (2017-2028)

Figure 60. China Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Metabolomics Biomarker Sales Market Share by Type (2017-2028)

Figure 67. South America Metabolomics Biomarker Sales Market Share by Application (2017-2028)

Figure 68. South America Metabolomics Biomarker Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Metabolomics Biomarker Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Metabolomics Biomarker Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Metabolomics Biomarker Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Metabolomics Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz